TruBridge, Inc. Common Stock (TBRG) is a publicly traded Healthcare sector company. As of May 21, 2026, TBRG trades at $25.94 with a market cap of $388.93M and a P/E ratio of -8.61. TBRG moved +0.04% today. Year to date, TBRG is +21.10%; over the trailing twelve months it is +4.09%. Its 52-week range spans $11.39 to $32.00. Analyst consensus is neutral with an average price target of $23.95. Rallies surfaces TBRG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TruBridge’s $26.25-Per-Share Sale Faces Law Firm Probe Over Fairness: Halper Sadeh LLC is probing TruBridge Inc.’s proposed $26.25-per-share cash sale to Inventurus Knowledge Solutions for potential securities law violations and breaches of fiduciary duty. The firm alleges insiders may receive substantial benefits and is seeking higher consideration or additional disclosures on behalf of shareholders at no upfront cost.
| Metric | Value |
|---|---|
| Price | $25.94 |
| Market Cap | $388.93M |
| P/E Ratio | -8.61 |
| EPS | $-3.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.00 |
| 52-Week Low | $11.39 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $312.73M |
| Net Income | $-272.95M |
| Gross Margin | 75.09% |
5 analysts cover TBRG: 0 strong buy, 0 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $23.95.